StockData
Carlsmed, Inc. logo

Carlsmed, Inc. (CARL) stock

CARLNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30123% above fair value
$17.42+0.20 (+1.16%)

Close on Nov 20, 2026Market cap $475.61MP/E –Yield –

Carlsmed free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Carlsmed's free cash flow for the twelve months ending Jun 30, 2026 was -$34.58M. For fiscal 2025 it was -$29.62M.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$29.62M–
FY2024Dec 31, 2024-$25.65M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$7.48M–
Q1 FY2026Mar 31, 2026-$13.09M–
Q4 FY2025Dec 31, 2025-$5.39M–
Q3 FY2025Sep 30, 2025-$8.62M–
Q2 FY2025Jun 30, 2025-$7.37M–
Q1 FY2025Mar 31, 2025-$8.24M–
Q4 FY2024Dec 31, 2024-$4.26M–
Q3 FY2024Sep 30, 2024-$7.63M–

More Carlsmed figures

See a number that looks wrong?